The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy.
Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands.
Myrte B
MB
Breukink
Anneke I
AI
den Hollander
Jan E E
JE
Keunen
Camiel J F
CJ
Boon
Carel B
CB
Hoyng
D000284:Administration, Oral; D000328:Adult; D056833:Central Serous Chorioretinopathy / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D002908:Chronic Disease; D000077545:Eplerenone; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D018161:Receptors, Mineralocorticoid / Q000378:metabolism; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
D000451:Mineralocorticoid Receptor Antagonists; D018161:Receptors, Mineralocorticoid; D013148:Spironolactone; D000077545:Eplerenone